Loading...
•
Jun 30, 2022
Select Medical Q2 2022 Earnings Report
Announced results for the second quarter ended June 30, 2022, and declared a cash dividend.
Key Takeaways
Select Medical Holdings Corporation reported a 1.3% increase in revenue to $1,584.7 million for the second quarter ended June 30, 2022, compared to $1,564.0 million for the same quarter, prior year. Net income was $66.3 million, compared to $196.2 million for the same quarter, prior year. Earnings per common share was $0.43, compared to $1.22 for the same quarter, prior year.
Revenue increased 1.3% to $1,584.7 million compared to the same quarter last year.
Net income decreased to $66.3 million compared to $196.2 million for the same quarter, prior year.
Earnings per common share decreased to $0.43 compared to $1.22 for the same quarter, prior year.
Select Medical reaffirms its 2022 business outlook for revenue, expecting consolidated revenue to be in the range of $6.25 billion to $6.40 billion.
Revenue by Segment
Forward Guidance
Select Medical reaffirms its 2022 business outlook for revenue and its previously issued three-year compound annual growth rate target for revenue only.
Positive Outlook
- Consolidated revenue is expected to be in the range of $6.25 billion to $6.40 billion for the full year of 2022.
- Three-year compound annual growth rate target for revenue is expected to be in the range of 4% to 6% for 2021 through 2023.
Challenges Ahead
- The company intends to address its business outlook and target compound annual growth rates for Adjusted EBITDA and earnings per common share when the labor climate stabilizes.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...